Interestingly, in contrast to the results of our studies in the rat ALS model and other reports5,20, we did not observe changes in the Atrogin-1 levels in ALS animals, despite the increase in the FOXO3a levels (Fig. S3). This evidence concerns the gene FOXO3 and amyotrophic lateral sclerosis.